Radiolabelling and cellular binding studies of metformin and indomethacin loaded dual niosome formulations on human colorectal adenocarcinoma cell line

Year 2025, Volume: 29 Issue: 3 , 1059 - 1066 , 04.06.2025

Meliha Ekinci , Emine Esin Çalışkan , Burak Çakar , Yalçın Çelik Aydın , Derya İlem-özdemir , Yiğit Uyanıkgil , Emel Öykü Çetin Uyanıkgil

https://doi.org/10.12991/jrespharm.1694207

https://izlik.org/JA64MD49CF

Abstract

In the current work, film hydration was used for producing indomethacin- and metformin-loaded dual niosomes with a particle size of < 150 nm, a polydispersity index of < 0.5, and a charge of between -30 and -50 mV. [99mTc]Tc was used as a radiolabel for all niosome formulations using stannous chloride as reducing agents. Radioactive thin-layer chromatography (RTLC) was used to evaluate the niosome formulations' radiochemical purity (RP) and stability. Next, the cellular binding of reduced/hydrolyzed (R/H)-[99mTc]NaTcO4 and [99mTc]Tc-labelled niosome formulations was evaluated in human colorectal adenocarcinoma cells. Radiolabelling all niosomes with [99mTc]Tc for 15 min at 500 μg.mL–1 stannous chloride resulted in successful radiolabelling, with an observed RP of over 95%. The cell binding percentages of [99mTc]Tc-labelled niosome formulations in cancer cells were higher than those of R/H- [99mTc]NaTcO4. Finally, the recently developed dual-niosome formulations of metformin and indomethacin labelled with [99mTc]Tc may prove effective for nuclear medicine imaging.

Keywords

Niosome , technetium-99m , radiolabelling , cell culture

References

• [1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7–30. https://doi.org/10.3322/caac.21590.
• [2] Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021; 10.1002/ijc.33588. https://doi.org/10.1002/ijc.33588.
• [3] Payolla FB, Massabni AC, Orvig C. Radiopharmaceuticals for diagnosis in nuclear medicine: A short review. Eclet Quim. 2019; 44(3): 11–19. https://doi.org/10.26850/1678-4618eqj.v44.3.2019.p11-19.
• [4] İlem-Özdemir D, Karavana SY, Şenyiğit ZA, Çalışkan Ç, Ekinci M, Asikoglu M, Baloglu E. Radiolabeling and cell incorporation studies of gemcitabine HCl microspheres on bladder cancer and papilloma cell line. J Radioanal Nucl Chem. 2016; 310(2): 515–522. https://doi.org/10.1007/s10967-016-4805-6.
• [5] Réti A, Barna G, Pap E, Adleff V, L Komlósi V, Jeney A, Kralovánszky J, Budai B. Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. Pathol Oncol Res. 2009; 15(3): 335-344. https://doi.org/10.1007/s12253-008-9126-9.
• [6] Skuli SJ, Alomari S, Gaitsch H, Bakayoko A, Skuli N, Tyler BM. Metformin and cancer, an ambiguanidous relationship. Pharmaceuticals (Basel). 2022; 15(5): 626. https://doi.org/10.3390/ph15050626.
• [7] De Silva L, Fu JY, Htar TT, Muniyandy S, Kasbollah A, Wan Kamal WHB, Chuah LH. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes. Int J Nanomedicine. 2019; 14: 1101–1117. https://doi.org/10.2147/IJN.S184912.
• [8] Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. Niosomes from 80s to present: The state of the art. Adv Colloid Interface Sci. 2014; 205: 187–206. https://doi.org/10.1016/j.cis.2013.11.018.
• [9] Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: A controlled and novel drug delivery system. Biol Pharm Bull. 2011; 34(7): 945–953. https://doi.org/10.1248/bpb.34.945.
• [10] Sohrabi S, Haeri A, Mahboubi A, Mortazavi A, Dadashzadeh S. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection. Int J Biol Macromol. 2016; 85: 625–633. https://doi.org/10.1016/j.ijbiomac.2016.01.013.
• [11] Ekinci M, Çalışkan EE, Çakar B, İlem-Özdemir D, Uyanıkgil Y, Çetin Uyanıkgil EÖ. [99mTc]Technetium-labeled niosomes: Radiolabeling, quality control, and in vitro evaluation. ACS Omega. 2023; 8(7): 6279–6288. https://doi.org/10.1021/acsomega.2c06179.
• [12] Monteiro LOF, Fernandes RS, Oda CMR, Lopes SC, Townsend DM, Cardoso VN, Oliveira MC, Leite EA, Rubello D, de Barros ALB. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study. Biomed Pharmacother. 2018; 97: 489–495. https://doi.org/10.1016/j.biopha.2017.10.135.
• [13] Chen M, Liu X, Fahr A. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. Int J Pharm. 2011; 408(1–2): 223–234. https://doi.org/10.1016/j.ijpharm.2011.02.006.
• [14] Cho NJ, Hwang LY, Solandt JJR, Frank CW. Comparison of extruded and sonicated vesicles for planar bilayer self-assembly. Materials (Basel). 2013; 6(8): 3294–3308. https://doi.org/10.3390/ma6083294.
• [15] Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003; 24(23): 4283–300. https://doi.org/10.1016/s0142-9612(03)00331-4.
• [16] Ekinci M, Yeǧen G, Aksu B, İlem-Özdemir D. Preparation and evaluation of poly(lactic acid)/poly(vinyl alcohol) nanoparticles using the quality by design approach. ACS Omega. 2022; 7(38): 33793-33807. https://doi.org/10.1021/acsomega.2c02141.
• [17] Helen Sonia A, Sambath Kumar R, Ruckmani K, Gover Antoniraj M, Bhama S. Formulation and characterization of nonionic surfactant/ cholesterol niosomes for abacavir sulphate encapsulation. Int J Res Pharm Sci. 2017; 8(2): 228-238.
• [18] Ekinci M, Ilem-Ozdemir D, Gundogdu E, Asikoglu M. Methotrexate loaded chitosan nanoparticles: Preparation, radiolabeling and in vitro evaluation for breast cancer diagnosis. J Drug Deliv Sci Technol. 2015; 30(A): 107–113. https://doi.org/10.1016/j.jddst.2015.10.004.
• [19] Ekinci M, Santos-Oliveira R, İlem-Özdemir D. Biodistribution of 99mTc-PLA/PVA/Atezolizumab nanoparticles for non-small cell lung cancer diagnosis. Eur J Pharm Biopharm. 2022; 176: 21–31. https://doi.org/10.1016/j.ejpb.2022.05.006.
• [20] Ekinci M, Öztürk AA, Santos-Oliveira R, İlem-Özdemir D. The use of Lamivudine-loaded PLGA nanoparticles in the diagnosis of lung cancer: Preparation, characterization, radiolabeling with 99mTc and cell binding. J Drug Deliv Sci Technol. 2022; 69: 103139. https://doi.org/10.1016/j.jddst.2022.103139.